Moderna’s mRNA Flu Shot Under Scrutiny

Is 26.6% efficacy worth a 75.7% side-effect rate? Three authors re-ran the FDA’s own mFLUSIVA data and found two unexplained deaths per hospitalization averted.

0 comments on “Moderna’s mRNA Flu Shot Under Scrutiny” Add yours →

Leave a Reply

Your email address will not be published. Required fields are marked *